Showing 51-60 of 108 results for "".
- Revance’s DaxibotulinumtoxinA for Injection Looks Good in Phase 2 Studies of Forehead Lines and Crow’s Feethttps://modernaesthetics.com/news/revances-daxibotulinumtoxina-for-injection-looks-good-in-phase-2-studies-of-forehead-lines-and-crows-feet/2472963/Revance Therapeutics, Inc.’s next-generation neuromodulator product, DaxibotulinumtoxinA, safely and effectively smoothed forehead lines and Crow’s feet with a median duration of 27 weeks in forehead lines and 24 weeks in crow’s feet achieved in at least one treatment group
- Kate Beckinsale Joins MRVL as the Face of its Anti-Aging Skin Care Linehttps://modernaesthetics.com/news/kate-beckinsale-joins-mrvl-as-the-face-of-its-anti-aging-skin-care-line-mrvl-skin-solutions/2473132/Kate Beckinsale is the face of MRVL Skin Solutions, an anti-aging skincare line launching this Fall. MRVL Skin Solutions is based on a novel ingredient in anti-aging: a Blue Scorpion Peptide. This peptide helps stimulate natural collagen production, fights free radicals, helps rege
- Clean Skincare Line Launches Rejuvenating Moisturizerhttps://modernaesthetics.com/news/clean-skincare-line-launches-rejuvenating-moisturizer/2473656/Topical Skin, a clean cosmeceutical company, launched a new rejuvenating moisturizer in July. The daily facial moisturizer contains niacinamide and is designed to provide intense hydration. Botanical-water and hyaluronic acid are blended with Vitamins E, C, and B to create a power
- Hologic's Cynosure Division Expands Body Contouring Linehttps://modernaesthetics.com/news/hologics-cynosure-division-expands-body-contouring-line/2471877/
- Done Deal: DermOQ Oxygen Lab Acquires ECHO2 Plus Oxygen Facial Treatment Product Line from Skin Products, Inc.https://modernaesthetics.com/news/done-deal-dermoq-oxygen-lab-acquires-echo2-plus-oxygen-facial-treatment-product-line-from-skin-products-inc/2473034/DermOQ Oxygen Lab closed their acquisition of ECHO2 Plus Oxyceuticals oxygen facial treatment product line from Skin Products, Inc. for an undisclosed amount. "ECHO2 Plus is a 45-minute facial treatment offered at physician's offices, spas, hotels and corporate custom
- Hydrafacial’s New HydraFillic with Pep9 Booster Targets Fine Line, Wrinkleshttps://modernaesthetics.com/news/hydrafacials-new-hydrafillic-with-pep9-booster-targets-fine-line-wrinkles/2475381/The Hydrafacial Company this week announced its latest innovation, the Hydrafacial HydraFillic with Pep9TM Booster. The HydraFillic with Pep9TM Booster is Hydrafacial’s first peptide-powered booster, formulated with a new proprietary complex of 9 peptides. It
- Analysis: PBoNT/A and ABoNT/A Show Fastest Onset in Glabellar Line Treatmenthttps://modernaesthetics.com/news/analysis-pbonta-and-abonta-show-fastest-onset-in-glabellar-line-treatment/2475374/A newly published study reports the comparative effects of four botulinum toxin A (BoNT/A) formulations on glabellar strain, with observed differences in onset, longevity, and muscular strain patterns.
- Clean Skincare Line Launches Age-Defying Peptide Serumhttps://modernaesthetics.com/news/clean-skincare-line-launches-age-defying-peptide-serum/2473623/Topical Skin, a clean cosmeceutical company, launched a new age-defying peptide serum. The goal of the serum is to combat signs of aging and reveal a youthful complexion. The age-defying peptide serum contains a blend of peptides, including Acetyl Tetrapeptide-5 and Acetyl Hexapep
- New From Alma: Alma TED, CBD+ Professional Linehttps://modernaesthetics.com/news/new-from-alma-alma-ted-cbd-professional-line/2473212/Alma TED, an Ultrasound-based system with a propriety Tip engineered with Impact Delivery™, offers a non-invasive, non-traumatic option to address the market's growing hair loss concerns. Alma launched the device, along with the CBD+ Professional S
- Revance: ePosters Showcase Data for DaxibotulinumtoxinA and RHA Line at Maui Dermhttps://modernaesthetics.com/news/revance-eposters-showcase-data-for-daxibotulinumtoxina-and-rha-line-at-maui-derm/2473053/Three ePosters presented at the Maui Derm for Dermatologists 2021 meeting feature data for DaxibotulinumtoxinA for Injection and the RHA® Collection of hyaluronic acid based dermal fillers, both from Revance Therapeutics. Revance repo